Bo Ahrén

21 – 30 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
40
next »

2020
Mark The incretin effect in female mice with double deletion of GLP-1 and GIP receptors
Ahrén, Bo ^LU ; Yamada, Yuichiro and Seino, Yutaka (2020) In Journal of the Endocrine Society 4(2).
- Contribution to journal › Article
Mark Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men
Lindgren, Ola ^LU and Ahrén, Bo ^LU (2020) In Endocrinology, Diabetes & Metabolism 3(3).
- Contribution to journal › Article
Mark Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
Alsalim, Wathik ^LU ; Göransson, Olga ^LU ; Tura, Andrea ; Pacini, Giovanni ; Mari, Andrea and Ahrén, Bo ^LU (2020) In Diabetes, Obesity and Metabolism 22(4). p.590-598
- Contribution to journal › Article
2019
Mark Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
Tura, Andrea ; Pacini, Giovanni ; Yamada, Yuchiro ; Seino, Yutaka and Ahrén, Bo ^LU (2019) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 316(1). p.27-37
- Contribution to journal › Article
Mark Glucagon-like peptide-1 receptor agonists for type 2 diabetes : A rational drug development
Ahrén, Bo ^LU (2019) In Journal of Diabetes Investigation 10(2). p.196-201
- Contribution to journal › Article
Mark Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
Farngren, Johan ^LU and Ahrén, Bo ^LU (2019) In Metabolism: Clinical and Experimental 99. p.25-31
- Contribution to journal › Article
Mark DPP-4 inhibition and the path to clinical proof
Ahrén, Bo ^LU (2019) In Frontiers in Endocrinology 10(JUN).
- Contribution to journal › Article
Mark Islet adaptation in GIP receptor knockout mice
Ahrén, Bo ^LU ; Yamada, Yuchiro and Seino, Yutaka (2019) In Peptides
- Contribution to journal › Scientific review
Mark Insulin and incretin hormone responses to rapid versus slow ingestion of a standardized solid breakfast in healthy subjects.
Alsalim, Wathik ^LU and Ahrén, Bo ^LU (2019) In Endocrinology, Diabetes & Metabolism 2(2). p.1-5
- Contribution to journal › Article
Mark Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).
Ahmadi, S. ; Filipsson, Karin ^LU ; Dimenäs, H ; Isaksson, S ; Imberg, H ; Sjöberg, Stefan ; Ahrén, Bo ^LU ; Dahlqvist, S ; Gustafsson, T and Tuomilehto, J , et al. (2019) In Obesity Science Practice 5(2). p.130-140
- Contribution to journal › Article

« previous
1
2
3
4
5
…
40
next »